Updated on 14 May 2012
They also plan to make kidney iPS cells from patients with inherited kidney diseases such as polycystic kidney disease and Alport disease. These cells in turn will provide human cell models to unmask how these diseases develop and search for drugs that can derail the process.
Melissa Little at the University of Queensland, while welcoming the step, said that, "This is an exciting development for this field of medicine. It opens the door to studies that may teach us about the nature of the problem in patients with kidney disease and screening for drugs that might help."
Get direct access to more such reports. Subscribe to BioSpectrum Bureau 
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
1Comment
Comment 1 - 1 of 1
faye haban 16 July 2012 at 12 PM
hi, can you please email me what hospitals in asia offers stemcell for kidneys. Thank you so much.
Reply